J Syh

SU-E-T-188: Commission of World 1st Commercial Compact PBS Proton System

Purpose: ProteusONE is the 1st commercial compact PBS proton system with an upstream scanning gantry and C230 cyclotron. We commissioned XiO and Raystation TPS simultaneously. This is a summary of beam data collection, modeling, and verification and comparison without range shiter for this unique system with both TPS. Methods: Both Raystation and XiO requires the same measurements data: (i) integral depth dose(IDDs) of single central spot measured in water tank; (ii) absolute dose calibration measured at 2cm depth of water with mono-energetic 10×10 cm2 field with spot spacing 4mm, 1MU per spot; and (iii) beam spot characteristics in air at 0cm and ± 20cm away from ISO. To verify the beam model for both TPS, same 15 cube plans were created to simulate different treatment sites, target volumes and positions. PDDs of each plan were measured using a Multi-layer Ionization Chamber(MLIC), absolute point dose verification were measured using PPC05 in water tank and patient-specific QA were measured using MatriXX PT, a 2D ion chamber array. Results: All the point dose measurements at midSOBP were within 2% for both XiO and Raystation. However, up to 5% deviations were observed in XiOs plans at shallow depth while within 2% in Raystation plans. 100% of the ranges measured were within 1 mm with maximum deviation of 0.5 mm. 20 patient specific plan were generated and measured in 3 planes (distal, proximal and midSOBP) in Raystation. The average of gamma index is 98.7%±3% with minimum 94% Conclusions: Both TPS were successfully commissioned and can be safely deployed for clinical use for ProteusONE. Based on our clinical experience in PBS planning, user interface, function and workflow, we preferably use Raystation as our main clinical TPS. Gamma Index >95% at 3%/3 mm criteria is our institution action level for patient specific plan QAs.

SU‐E‐T‐136: Comparison of TomoScanner™ 2D Water Phantom versus IBA Helix for Tomotherapy Profile Measurements

PURPOSE To compare the differences in measured data using Tomotherapys TomoScanner™ 2D Water Phantom versus IBAs Blue Phantom Helix taken during commissioning of the Tomotherapy HD unit. METHODS IBA Helix was used with CC04 ion chamber to measure Inline (jaw-size width), Crossline (40 cm width) and Percent Depth Dose (PDD). Data was analyzed using IBA Omni-Pro 7.3 software. Measurements were performed at 85 SSD for field sizes 5×40 cm2 , 2.5×40 cm2 , and 1.0×40 cm2 . All field sizes were measured at 1.5 cm (nominal dmax), 5 cm, 10 cm and 15 cm depths. Scans were performed at a continuous speed setting of 0.5 cm/sec. Setup and data measurements were performed twice on separate occasions for consistency and repeatability. Data measurements were normalized to 10 cm depth and compared to commissioning data taken from TomoScanner™ and Tomotherapys Twinning Data. RESULTS For all jaws, the profiles measured at 5 cm, 10 cm, and 15 cm depth using IBA Helix matched the profiles of the TomoScanner™ data within 1%. Profile variance at 1.5 cm depth showed a deviation of up to 3%. For all jaws, the PDD comparisons displayed 3-5% deviation from the surface to 2 cm depth and within 1% deviation at 2 cm to 15 cm depth. Measurements performed using CC04 ion chamber versus A1SL ion chamber (used by Standard Imaging) showed data differences of less than 0.5%. CONCLUSIONS Discrepancies in Tomotherapy beam profiles were observed between different water phantoms. Further investigation is required to determine the cause of variances between IBA and Tomotherapy data sets such as investigating geometrical differences between the water tanks and software dissimilarities in collecting and correcting raw data. It is recommended that independent commissioning data be taken when TomoScanner™ is not the clinical sites standard water phantom.

SU‐E‐T‐09: A Clinical Implementation and Optimized Dosimetry Study of Freiberg Flap Skin Surface Treatment in High Dose Rate Brachytherapy

Purpose: This case study was designated to confirm the optimized plan was used to treat skin surface of left leg in three stages. 1. To evaluate dose distribution and plan quality by alternating of the source loading catheters pattern in flexible Freiberg Flap skin surface (FFSS) applicator. 2. To investigate any impact on Dose Volume Histogram (DVH) of large superficial surface target volume coverage. 3. To compare the dose distribution if it was treated with electron beam. Methods: The Freiburg Flap is a flexible mesh style surface mold for skin radiation or intraoperative surface treatments. The Freiburg Flap consists of multiple spheres that are attached to each other, holding and guiding up to 18 treatment catheters. The Freiburg Flap also ensures a constant distance of 5mm from the treatment catheter to the surface. Three treatment trials with individual planning optimization were employed: 18 channels, 9 channels of FF and 6 MeV electron beam. The comparisons were highlighted in target coverage, dose conformity and dose sparing of surrounding tissues. Results: The first 18 channels brachytherapy plan was generated with 18 catheters inside the skin-wrapped up flap (Figure 1A). A second 9 catheters plan was generated associated with the same calculation points which were assigned to match prescription for target coverage as 18 catheters plan (Figure 1B). The optimized inverse plan was employed to reduce the dose to adjacent structures such as tibia or fibula. The comparison of DVH’s was depicted on Figure 2. External beam of electron RT plan was depicted in Figure 3. Overcall comparisons among these three were illustrated in Conclusion: The 9-channel Freiburg flap flexible skin applicator offers a reasonably acceptable plan without compromising the coverage. Electron beam was discouraged to use to treat curved skin surface because of low target coverage and high dose in adjacent tissues.

SU‐E‐T‐280: Dose Evaluation in Using CT Density Versus Relative Stopping Power for Pencil Beam Planning and Treating IROC Proton Phantom

Purpose: The purpose of this study is to evaluate any effects of converted CT density variation in treatment planning system (TPS) of spot scanning proton therapy with an IROC proton prostate phantom at our new ProteusOne Proton Therapy Center. Methods: A proton prostate phantom was requested from the Imaging and Radiation Oncology Core Houston (IROC), The University of Texas MD Anderson Cancer Center, Houston, TX, where GAF Chromic films and couples of thermo luminescent dosemeter (TLD) capsules in target and adjacent structures were embedded for imaging and dose monitoring. Various material such as PVC, PBT HI polystyrene as dosimetry inserts and acrylic were within phantom. Relative stopping power (SP) were provided. However our treatment planning system (TPS) doesn’t require SP instead relative density was converted relative to water in TPS. Phantom was irradiated and the results were compared with IROC measurements. The range of relative density was converted from SP into relative density of water as a new assigned material and tested. Results: The summary of TLD measurements of the prostate and femoral heads were well within 2% of the TPS and met the criteria established by IROC. The film at coronal plane was found to be shift in superior-inferior direction due to locking position of cylinder insert was off and was corrected. The converted CT density worked precisely to correlated relative stopping power. Conclusion: The proton prostate phantom provided by IROC is a useful methodology to evaluate our new commissioned proton pencil beam and TPS within certain confidence in proton therapy. The relative stopping power was converted into relative physical density relatively to water and the results were satisfied.

SU-E-T-636: ProteusONE Machine QA Procedure and Stabiity Study: Half Year Clinical Operation

Purpose: The objective of this study is to evaluate the stability of ProteusOne, the 1st commercial PBS proton system, throughout the daily QA and monthly over 6 month clinical operation. Method: Daily QA test includes IGRT position/repositioning, output in the middle of SOBP, beam flatness, symmetry, inplane and crossplane dimensions as well as energy range check. Daily range shifter QA consist of output, symmetry and field size checks to make sure its integrity. In 30 mins Daily QA test, all the measurements are performed using the MatriXXPT (IBA dosimetry). The data from these measurement was collected and compare over the first 6 month of clinical operation. In addition to the items check in daily QA, the summary also includes the monthly QA gantry star shots, absolute position check using a novel device, XRV-100. Results: Average machine output at the center of the spread out bragg peak was 197.5±.8 cGy and was within 1%of the baseline at 198.4 cGy. Beam flatness was within 1% cross plane with an average of 0.67±0.12% and 2% in-plane with an average of 1.08±0.17% compared to baseline measurements of 0.6 and 1.03, respectively. In all cases the radiation isocenter shift was less than or equal to 1mm. Output for the range shifter was within 2% for each individual measurement and averaged 34.4±.2cGy compare to a baseline reading of 34.5cGy. The average range shifter in and cross plane field size measurements were 19.8±0.5cm and 20.5±0.4cm compared with baseline values of 20.19cm and 20.79cm, respectively. Range shifter field symmetry had an average of less 1% for both in-plane and cross plane measurements. Conclusion: All machine metrics over the past 6 months have proved to be stable. Although, some averages are outside the baseline measurement they are within 1% tolerance and the deviation across all measurements is minimal.

SU-E-T-10: A Clinical Implementation and the Dosimetric Evidence in High Dose Rate Vaginal Multichannel Applicator Brachytherapy

Purpose: The multichannel cylindrical applicator has a distinctive modification of the traditional single channel cylindrical applicator. The novel multichannel applicator has additional peripheral channels that provide more flexibility both in treatment planning process and outcomes. To protect by reducing doses to adjacent organ at risk (OAR) while maintaining target coverage with inverse plan optimization are the goals for such novel Brachytherapy device. Through a series of comparison and analysis of reults in more than forty patients who received HDR Brachytherapy using multichannel vaginal applicator, this procedure has been implemented in our institution. Methods: Multichannel planning was CT image based. The CTV of 5mm vaginal cuff rind with prescribed length was well reconstructed as well as bladder and rectum. At least D95 of CTV coverage is 95% of prescribed dose. Multichannel inverse plan optimization algorithm not only shapes target dose cloud but set dose avoids to OAR’s exclusively. The doses of D2cc, D5cc and D5; volume of V2Gy in OAR’s were selected to compare with single channel results when sole central channel is only possibility. Results: Study demonstrates plan superiorly in OAR’s doe reduction in multi-channel plan. The D2cc of the rectum and bladder were showing a little lower for multichannel vs. single channel. The V2Gy of the rectum was 93.72% vs. 83.79% (p=0.007) for single channel vs. multichannel respectively. Absolute reduced mean dose of D5 by multichannel was 17 cGy (s.d.=6.4) and 44 cGy (s.d.=15.2) in bladder and rectum respectively. Conclusion: The optimization solution in multichannel was to maintain D95 CTV coverage while reducing the dose to OAR’s. Dosimetric advantage in sparing critical organs by using a multichannel applicator in HDR Brachytherapy treatment of the vaginal cuff is so promising and has been implemented clinically.

SU‐E‐T‐662: Quick and Efficient Daily QA for Compact PBS Proton Therapy Machine

Purpose: As proton therapy machines become widespread the need for a quick simple routine daily QA like that for linear accelerators becomes more important. Willis-Knighton has developed an accurate and efficient daily QA that can be performed in 15 minutes. Methods: A holder for a 2D ionization chamber array (MatriXX PT) was created that is indexed to the couch to allow for quick setup, lasers accuracy with respect to beam isocenter, and couch reproducibility. Image position/reposition was performed to check Isocentricity accuracy by placing BBs on the MatriXX. The couch coordinates are compared to that of commissioning. Laser positions were confirmed with the MatriXX isocenter. After IGRT, three beams were separately delivered according to setup. For the first beam, range shifter was inserted and dose at R90, field size, flatness and symmetry in X and Y direction was measured. R90 was used so any minor changes in the range shifter can be detected. For the open beam, dose at center of SOBP, flatness and symmetry in X and Y direction was measured. Field size was measured in ±X and ±Y direction at FWHM. This is measured so any variation in spot size will be detected. For the third beam additional solid water was added and dose at R50 was measured so that any variation in beam energy will be detected. Basic mechanical and safety checks were also performed. Results: Medical physicists were able to complete the daily QA and reduce the time by half to two-third from initial daily QA procedure. All the values measured were within tolerance of that of the baseline which was established from water tank and initial MatriXX measurements. Conclusion: The change in daily QA procedure resulted in quick and easy setup and was able to measure all the basic functionality of the proton therapy PBS.

SU-E-T-110: An Investigation On Monitor Unit Threshold and Effects On IMPT Delivery in Proton Pencil Beam Planning System

Purpose: An approved proton pencil beam scanning (PBS) treatment plan might not be able to deliver because of existed extremely low monitor unit per beam spot. A dual hybrid plan with higher efficiency of higher spot monitor unit and the efficacy of less number of energy layers were searched and optimized. The range of monitor unit threshold setting was investigated and the plan quality was evaluated by target dose conformity. Methods: Certain limitations and requirements need to be checks and tested before a nominal proton PBS treatment plan can be delivered. The plan needs to be met the machine characterization, specification in record and verification to deliver the beams. Minimal threshold of monitor unit, e.g. 0.02, per spot was set to filter the low counts and plan was re-computed. Further MU threshold increment was tested in sequence without sacrificing the plan quality. The number of energy layer was also alternated due to elimination of low count layer(s). Results: Minimal MU/spot threshold, spot spacing in each energy layer and total number of energy layer and the MU weighting of beam spots of each beam were evaluated. Plan optimization between increases of the spot MU (efficiency) and less energy layers of delivery (efficacy) was adjusted. 5% weighting limit of total monitor unit per beam was feasible. Scarce spreading of beam spots was not discouraging as long as target dose conformity within 3% criteria. Conclusion: Each spot size is equivalent to the relative dose in the beam delivery system. The energy layer is associated with the depth of the targeting tumor. Our work is crucial to maintain the best possible quality plan. To keep integrity of all intrinsic elements such as spot size, spot number, layer number and the carried weighting of spots in each layer is important in this study.

SU‐E‐T‐200: IBA ProteusOne Compact Proton Therapy System Radiation Survey Results

PURPOSE This study summarizes the results of an initial radiation survey of the Willis-Knighton Cancer Center in Shreveport, Louisiana. The facility houses an IBA ProteusOne compact single room proton therapy unit coupled with a C230 cyclotron that operates at a maximum energy of 230 MeV. METHODS A calibrated survey meter was used for the photon measurements to obtain reliable results. A neutron detector was used as the measuring instrument for neutrons. The locations of the survey and measurements were planned carefully in order to get a proper evaluation of the facility shielding configuration. The walls, ceiling, vault entrance, and the adjacent environment were each surveyed with suitable measurement instruments. A total of 22 locations were chosen for radiation survey. Dose equivalent values were calculated for both the photon and the neutron radiation using measured data. RESULTS All measured dose values are presented in millisievert per year. The highest dose measured at the vault entrance is 0.34 mSv/year. A dedicated shielding door was not present at the time of the measurement. The vault entrance area is considered as a controlled area. The shielding design goals are not to exceed 5 mSv/year for the controlled area and 1 mSv/year the uncontrolled area. The total combined neutron and photon dose equivalent values were found to be compliant with the Louisiana Department of Environmental Quality radiation protection regulatory codes. CONCLUSION In our efforts to evaluate the radiation levels at the Willis-Knighton Cancer Center proton treatment facility, we have found that all the measured values of the radiation shielding are below the critical radiation limits per year. Since the total dose measured at the vault entrance is below the shielding design goal, a shielding door is not required at this proton treatment vault.

SU-F-19A-03: Dosimetric Advantages in Critical Structure Dose Sparing by Using a Multichannel Cylinder in High Dose Rate Brachytherapy to Treat Vaginal Cuff Cancer

PURPOSE The multichannel cylindrical vaginal applicator is a variation of traditional single channel cylindrical vaginal applicator. The multichannel applicator has additional peripheral channels that provide more flexibility in the planning process. The dosimetric advantage is to reduce dose to adjacent organ at risk (OAR) such as bladder and rectum while maintaining target coverage with the dose optimization from additional channels. METHODS Vaginal HDR brachytherapy plans are all CT based. CT images were acquired in 2 mm thickness to keep integrity of cylinder contouring. The CTV of 5mm Rind with prescribed treatment length was reconstructed from 5mm expansion of inserted cylinder. The goal was 95% of CTV covered by 95% of prescribed dose in both single channel planning (SCP)and multichannel planning (MCP) before proceeding any further optimization for dose reduction to critical structures with emphasis on D2cc and V2Gy . RESULTS This study demonstrated noticeable dose reduction to OAR was apparent in multichannel plans. The D2cc of the rectum and bladder were showing the reduced dose for multichannel versus single channel. The V2Gy of the rectum was 93.72% and 83.79% (p=0.007) for single channel and multichannel respectively (Figure 1 and Table 1). To assure adequate coverage to target while reducing the dose to the OAR without any compromise is the main goal in using multichannel vaginal applicator in HDR brachytherapy. CONCLUSION Multichannel plans were optimized using anatomical based inverse optimization algorithm of inverse planning simulation annealing. The optimization solution of the algorithm was to improve the clinical target volume dose coverage while reducing the dose to critical organs such as bladder, rectum and bowels. The comparison between SCP and MCP demonstrated MCP is superior to SCP where the dwell positions were based on geometric array only. It concluded that MCP is preferable and is able to provide certain features superior to SCP.